FDA warns 18 websites over unapproved Botox
The U.S. Food and Drug Administration sent warning letters to 18 websites for selling counterfeit or unapproved versions of Botox and similar injectables, citing reported injuries and toxic side effects. Announced Wednesday, the FDA urged patients to receive injections only from licensed, trained health professionals and warned that botulism-like symptoms after treatment require immediate medical care.
This story is compiled from 1 source using AI-assisted curation and analysis. Original reporting is attributed below. Learn about our methodology.
đ Key Facts
- FDA issued 18 warning letters to cosmetic websites on Nov. 5, 2025
- Agency cites injury reports linked to unapproved/counterfeit injectables
- FDA advises using licensed providers and watching for botulism symptoms (e.g., difficulty breathing/swallowing)
đ° Source Timeline (1)
Follow how coverage of this story developed over time
November 05, 2025